💥 HBAR price nears breakout as inverse head and shoulders pattern forms
HBAR price is consolidating below key resistance as an inverse head and shoulders pattern develops, signaling a potential bullish breakout if the neckline resistance is cleared with volume.
HBAR ($HBAR ) price action is showing increasingly constructive behavior as the market builds a classic bullish reversal structure on the higher timeframes. After an extended corrective phase, price has stabilized and begun forming an inverse head and shoulders pattern, a formation often associated with trend reversals when confirmed
Insperity's Q4 losses widen as high benefit costs drag down performance
Houston - Human Resources and Business Performance Solutions Provider Insperity, Inc. (NYSE:NSP) reported a quarterly loss that exceeded expectations, despite a slight increase in revenue, as high benefit costs continued to pressure profitability.
The company posted an adjusted quarterly loss of $0.60 per share, compared to analysts’ estimates of a $0.47 per share loss. Revenue rose 3% year-over-year to $1.67 billion, slightly below the consensus estimate of $1.68 billion. The stock remained unchanged after the announcement.
Insperity’s fourth-quarter performance was mainly impacted by a 21% decline in gross profit to $172 million, primarily due to “persistently high benefit costs” related to inpatient, outpatient, and pharmacy trends, as well as increased frequency of large claims. This overshadowed the company’s achievement of a 1% increase in average paid Worksite Employees (WSEEs) to 312,377.
Chairman and CEO Paul J. Sarvadi stated, “We achieved key milestones during the year-end transition, with improved gross margins, and we believe this will significantly restore the company’s profitability this year.”
For the full fiscal year 2025, Insperity reported a net loss of $7 million, or $0.19 per share, compared to net income of $91 million, or $2.42 per share, in 2024. Adjusted EBITDA decreased from $270 million last year to $131 million.
Looking ahead, the company provided guidance for fiscal 2026 with an adjusted EPS range of $1.69 to $2.72, with a median of $2.21, below analysts’ expectations of $2.44 per share. Insperity expects the average WSEEs for the year to be between 305,400 and 314,700.
Chief Financial Officer James D. Allison stated, “In 2025, we addressed profitability challenges and took significant measures aimed at restoring margins through pricing and customer selection, new contracts and plan design changes with UnitedHealth, and operational expense efficiencies.”
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.